Sramana Mitra: We have a little company within the 1Mby1M program called CleaningUp. Their discovery is that, as you said, a huge percentage of the workflow of drug development is still on paper and not digital. Especially when trials are held in international locations, people fill out papers. They’re trying to transform that process into
Sramana Mitra: In the last 30 days, we’ve done story after story analyzing what’s happening on the acquisition side of B2B SaaS. I think one of the things that’s very attractive about Arka is that you’re not chasing unicorns and I’ll let you elaborate on that. Yash Hemaraj: You’re right on the point that a
Arihant Patni is Managing Director at Ideaspring Capital, a fund focused on enterprise companies born in India and selling to the global market.
Sramana Mitra: In 1Mby1M, we have a rolling admission. Anyone can join at any time. There’s no three-month program. There’s no concept of graduation. We’re building companies. What would you graduate from? We don’t believe in graduation from an accelerator really. I think these are important points, important differentiators, and important markers to pay attention
The clinical data domain is going through major changes and is full of opportunities. This discussion delves into the industry with one of its biggest players. Sramana Mitra: Let’s introduce our audience to you as well as Medidata. Tarek Sherif: I’m Tarek Sherif. I’m a Co-Founder, the CEO, and Chairman of Medidata Solutions. We’re a
This feature from CNET follows the annual Game Developers Conference held in San Francisco last week. For this week’s posts, click on the paragraph links.
Rahul Chowdhri, Investor at Stellaris Venture Partners, shares some fascinating examples of consumer ventures catering to the next 400 million consumers in India.
Sramana Mitra: In selecting customers to go after, what is the positioning of your company? Are you going after large enterprises? Are you going after mid-market? Are you going after small businesses? Each of them has a slightly different go-to market strategy. The inside sales point that you raise is very interesting. Freshdesk, now Freshworks,